Citation only
via OpenAlex
A novel strategy by pharmacological reprogramming reverses endothelial senescence and improves vascular regeneration
Katrin Kalies, Kai Knoepp, Leonie Wurmbrand, Jochen Dutzmann, Daniel Sedding
European Heart Journal · 2025
Telomere attrition
Mitochondrial dysfunction
Cellular senescence
Partial reprogramming (OSK)
Cell culture / in vitro
Mouse
In vitro
Abstract
Abstract Endothelial cell (EC) senescence(definition) plays a crucial role in the development of cardiovascular diseases, leading to impaired angiogenesis and regeneration. Reversing EC senescence is therefore a promising therapeutic approach to restore vascular function and promote overall health and longevity. In this study, we demonstrate that senescent ECs can be rejuvenated using a pharmacological, non-genetic partial reprogramming(definition) strategy that transiently activates the Yamanaka factors Oct3/4, Sox2, Klf4, and c-Myc (OSKM). To assess the effects of pharmacological reprogramming, we conducted gene expression analyses and functional assays in EC in vitro. Additionally, we evaluated the regenerative potential of ECs in a hind-limb ischemia model in young and aged C57BL/6J mice. Treatment with the reprogramming cocktail induced a transient yet robust activation of OSKM at both mRNA and protein levels (p<0.0001) in replicative senescent ECs. This was accompanied by a significant reduction in senescence-associated markers, including p16ink4a, p14arf, TNFα, IL-1b, IL-6, and CD44 (p<0.01 to p<0.0001), as well as an improvement in cellular function. Specifically, reprogrammed ECs exhibited enhanced migration (p<0.001), proliferation (p<0.01), sprouting (p<0.0001), and tube formation (p<0.01). Furthermore, telomere(definition) length was stabilized (p<0.05) and reactive oxygen species production decreased (p<0.05). Notably, non-senescent ECs remained unaffected by the treatment (p>0.05). Over time, reprogrammed ECs retained low expression of senescence markers (p16ink4a and p14arf, p<0.01) while maintaining their migratory capacity (p<0.05). In vivo, aged (22-month-old) mice exhibited significantly improved blood flow following hind-limb ischemia after 7 and 14 days of treatment (p<0.001), along with increased capillary density in the gastrocnemius muscle as indicated by CD31 staining (p<0.05). In contrast, young (3-month-old) mice showed no significant changes in blood flow (p>0.05). In summary, our findings demonstrate that transient pharmacological activation of OSKM effectively reverses endothelial senescence in vitro, enhancing regenerative and angiogenic functions. This strategy holds significant potential for improving endothelial repair in vivo and may offer a novel therapeutic approach for ischemic diseases.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1093/eurheartj/ehaf784.4842
- Canonical
- link ↗
- Fetched
- 2026-10-09 MST
Cite this
APA
Kalies, K., Knoepp, K., Wurmbrand, L., Dutzmann, J., & Sedding, D. (2025). A novel strategy by pharmacological reprogramming reverses endothelial senescence and improves vascular regeneration. <em>European Heart Journal</em>. https://doi.org/10.1093/eurheartj/ehaf784.4842
Vancouver
Kalies K, Knoepp K, Wurmbrand L, Dutzmann J, Sedding D. A novel strategy by pharmacological reprogramming reverses endothelial senescence and improves vascular regeneration. European Heart Journal. 2025. doi:10.1093/eurheartj/ehaf784.4842.
BibTeX
@article{katrin2025Anovel,
title = {A novel strategy by pharmacological reprogramming reverses endothelial senescence and improves vascular regeneration},
author = {Katrin Kalies and Kai Knoepp and Leonie Wurmbrand and Jochen Dutzmann and Daniel Sedding},
journal = {European Heart Journal},
year = {2025},
doi = {10.1093/eurheartj/ehaf784.4842},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Circulation 2025
Citation only
Abstract 4366240: Transient pharmacological reprogramming reverses endothelial senescence and promotes vascular regeneration
Basic Research in Cardiology 2026
Open access · CC-BY
Functional rejuvenation of endothelial cell aging by transient reprogramming
Basic research in cardiology 2026
Citation only
Functional rejuvenation of endothelial cell aging by transient reprogramming.
Aging Cell 2023
Open access · CC-BY
Rutin is a potent senomorphic agent to target senescent cells and can improve chemotherapeutic efficacy
Molecular Metabolism 2018
Open access · CC-BY
Insulin-like growth factor receptor signaling regulates working memory, mitochondrial metabolism, and amyloid-β uptake in astrocytes
Journal of Bone and Mineral Research 2016
Preprint · OA